To examine the mechanism via which SGLT2i stimulated basal EGP, individuals with T2D received dapagliflozin under conditions in which the plasma insulin, glucagon, and glucose concentrations were clamped at the fasting level alone or in combination via the pancreatic clamp technique (11). Here, INS is linked to type 2 diabetes mellitus.